|
Model Number FG15150-0615-1S |
Device Problems
Break (1069); Difficult to Remove (1528); Physical Resistance/Sticking (4012)
|
Patient Problem
Foreign Body In Patient (2687)
|
Event Date 12/14/2022 |
Event Type
Injury
|
Event Description
|
Medtronic received a report that the physicians were attempting to navigate both the wahoo guide catheter and phenom 27 microcatheter into position over the wire in order to place a pipeline shield flow diverter in the internal carotid artery (ica).While advancing the wahoo, the physician noted resistance.The physician also noted resistance while trying to advance the phenom 27 through the wahoo guide catheter.It was at this point there was concern and decided to try to remove the phenom 27 from the wahoo.While pulling back on the phenom 27, he once again noticed resistance and paused to review the imaging.It was at this point he noticed that the radiopaque tip of the phenom 27 had broken off and was floating in the wahoo.Almost immediately, the broken tip then embolized to the right m3.It wedged itself tightly into the m3 with the inner lumen open and in the orientation of the artery, preserving flow through the m3.It was unclear to the physician if the wahoo kinked and trapped the phenom causing resistance, or if the loop on the distal end of the wire had folded back on the microcatheter causing it to become entrapped.The physician then swapped out the wahoo/phenom 27 for a bmx, navien <(>&<)> another phenom 27 and successfully deployed the pipeline.In the post deployment runs the m3 was still open/patent with no signs of thrombin formation or coagulation.Patient is on duapt.The reported device and any accessory devices were prepared as indicated in the ifu.The catheter was flushed as indicated in the ifu.No patient symptoms or complication were reported.The patient was undergoing surgery to reconstruct affected ica segment.It was noted the patient's vessel tortuosity was moderate.The access vessel was the femoral artery.Ancillary devices include a wahoo guide catheter and phenom 27 microcatheter.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported that the hcp does not intend to try to retrieve the tip in the future.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|